IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Current Drug Therapy

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

0.81

h-Index

2024-2025

 21

Rank

2024-2025

 22722

SJR

2024-2025

 0.176

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Current Drug Therapy
Abbreviation Curr. Drug Ther.
Publication Type Journal
Subject Area, Categories, Scope Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)
h-index 21
Overall Rank/Ranking 22722
SCImago Journal Rank (SJR) 0.176
Impact Score 0.81
Publisher Bentham Science Publishers
Country United Arab Emirates
ISSN 15748855, 22123903
Best Quartile Q3
Coverage History 2007-2025




About Current Drug Therapy


Current Drug Therapy is a journal covering the technologies/fields/categories related to Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4). It is published by Bentham Science Publishers. The overall rank of Current Drug Therapy is 22722. According to SCImago Journal Rank (SJR), this journal is ranked 0.176. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 21. The best quartile for this journal is Q3.

The ISSN of Current Drug Therapy journal is 15748855, 22123903. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Current Drug Therapy is cited by a total of 79 articles during the last 3 years (Preceding 2024).


Current Drug Therapy Impact IF 2024-2025


The Impact IF 2024 of Current Drug Therapy is 0.81, which is computed in 2025 as per its definition. Current Drug Therapy IF is increased by a factor of 0.41 and approximate percentage change is 102.5% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Current Drug Therapy Impact IF 2025 Prediction


Impact IF 2024 of Current Drug Therapy is 0.81. If the same upward trend persists, Impact IF may rise in 2025 as well.


Impact IF Trend


Year wise Impact IF of Current Drug Therapy. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 0.81
2023 0.40
2022 0.71
2021 0.84
2020 0.54
2019 0.47
2018 0.53
2017 0.68
2016 0.37
2015 0.52
2014 0.32

Current Drug Therapy h-index


  Table Setting

Current Drug Therapy has an h-index of 21. It means 21 articles of this journal have more than 21 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Current Drug Therapy ISSN


The ISSN of Current Drug Therapy is 15748855, 22123903. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Current Drug Therapy Rank and SCImago Journal Rank (SJR)


The overall rank of Current Drug Therapy is 22722. According to SCImago Journal Rank (SJR), this journal is ranked 0.176. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Current Drug Therapy by Year


Year SJR
2025/2026 Coming Soon
2024 0.176
2023 0.171
2022 0.169
2021 0.175
2020 0.174
2019 0.160
2018 0.138
2017 0.161
2016 0.165
2015 0.183
2014 0.154

Ranking of Current Drug Therapy by Year


Year Ranking
2025/2026 Coming Soon
2024 22722
2023 21666
2022 20807
2021 19757
2020 21100
2019 21005
2018 22602
2017 20046
2016 20010
2015 18609
2014 20291

Current Drug Therapy Publisher


Table Setting

Current Drug Therapy is published by Bentham Science Publishers. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2007-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Current Drug Therapy is Curr. Drug Ther.. This abbreviation ('Curr. Drug Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Current Drug Therapy


If your research field is/are related to Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Current Drug Therapy?

Current Drug Therapy latest impact IF is 0.81. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 0.84 (2021) and 0.32 (2014), respectively, in the last 11 years. Moreover, its average IS is 0.56 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Current Drug Therapy?

The Current Drug Therapy has an SJR (SCImago Journal Rank) of 0.176, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.183 in 2015 and the lowest being 0.138 in 2018. Furthermore, the average SJR of the Current Drug Therapy over the previous 11-year period stands at 0.56.


What's the latest h-index of the Current Drug Therapy?

The latest h-index of the Current Drug Therapy is 21.


Who's the publisher of the Current Drug Therapy?

The Current Drug Therapy is published by the Bentham Science Publishers, with its country of publication being the United Arab Emirates.


What's the current ranking of the Current Drug Therapy?

The Current Drug Therapy is currently ranked 22722 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 18609 in 2015 and its lowest position of 22722 in 2024.


What's the abbreviation or short name for the Current Drug Therapy?

The standard ISO4 abbreviation for the Current Drug Therapy is Curr. Drug Ther..


Is the "Current Drug Therapy" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Current Drug Therapy is classified as a journal that the Bentham Science Publishers publishes.


What's the scope or major areas of the Current Drug Therapy?

The Current Drug Therapy encompasses the following areas:

  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Pharmacology (medical)

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Current Drug Therapy?

The Current Drug Therapy is assigned the following International Standard Serial Numbers (ISSN): 15748855, 22123903.


What's the best quartile of the Current Drug Therapy?

The best quartile for the Current Drug Therapy is Q3 (2024).


What's the coverage history of the Current Drug Therapy?

The Current Drug Therapy coverage history can be summarized as follows: 2007-2025.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Indian Journal of Plastic Surgery journal 30965 Georg Thieme Verlag 44 0.46
Business: Theory and Practice journal 16073 Vilnius Gediminas Technical University 31 2.45
Journal of Field Archaeology journal 7683 Maney Publishing 48 1.85
SPE Production and Operations Symposium, Proceedings conference and proceedings 15907 21 0.00
Business Strategy Review journal 31512 Wiley-Blackwell Publishing Ltd 33 0.04
Archives of Phytopathology and Plant Protection journal 16692 Taylor and Francis Ltd. 35 1.42
Howard Journal of Communications journal 14582 Taylor and Francis Ltd. 42 1.27
Museum Management and Curatorship journal 10490 Routledge 43 2.06
Journal of Sociology journal 6357 SAGE Publications Ltd 66 2.82
Engenharia Agricola journal 17944 Sociedade Brasileira de Engenharia Agricola 33 0.94

Check complete list




Year wise Impact Score (IS) of Current Drug Therapy

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 0.81
2023 0.40
2022 0.71
2021 0.84
2020 0.54
2019 0.47
2018 0.53
2017 0.68
2016 0.37
2015 0.52
2014 0.32



Top Journals/Conferences in Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Acta Pharmaceutica Sinica B
Chinese Academy of Medical Sciences | China

Theranostics
Ivyspring International Publisher | Australia

Current Protocols
John Wiley and Sons Inc | United States

Acta Materia Medica
Compuscript Ltd | Ireland

PLoS Neglected Tropical Diseases
Public Library of Science | United States

Life Sciences
Elsevier Inc. | United States

Clinical and Translational Science
John Wiley and Sons Inc | United Kingdom

Nanotheranostics
Ivyspring International Publishers | Australia

Frontiers in Toxicology
Frontiers Media SA | Switzerland

Antibiotics
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Drugs
| Switzerland

Journal of Biomedical Science
BioMed Central Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Alimentary Pharmacology and Therapeutics
John Wiley and Sons Inc | United Kingdom

American Journal of Transplantation
Elsevier B.V. | Netherlands

Acta Pharmacologica Sinica
Springer Nature | United Kingdom

BioDrugs
| Switzerland

npj Vaccines
Nature Publishing Group | United Kingdom

See All